Trends in Drug Development Costs, Times, and Risks
- 1 April 1995
- journal article
- Published by Springer Nature in Drug Information Journal
- Vol. 29 (2) , 375-384
- https://doi.org/10.1177/009286159502900204
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Research and Development Costs for New Drugs by Therapeutic CategoryPharmacoEconomics, 1995
- New drug development in the United States from 1963 to 1992Clinical Pharmacology & Therapeutics, 1994
- New drug development in the United States from 1963 to 1990Clinical Pharmacology & Therapeutics, 1991
- Cost of innovation in the pharmaceutical industryJournal of Health Economics, 1991
- New drug development in the United States, 1963 through 1984Clinical Pharmacology & Therapeutics, 1988
- New drug development during and after a period of regulatory change: Clinical research activity of major united states pharmacxeutical firms, 1958 to 1979Clinical Pharmacology & Therapeutics, 1983
- Development of new drugs originated and acquired by United States–owned pharmaceutical firms, 1963-1976*Clinical Pharmacology & Therapeutics, 1980
- The rate of development of new drugs in the United States, 1963 through 1975Clinical Pharmacology & Therapeutics, 1978